» Articles » PMID: 16087715

Characterization of the Early Stages of Thymic NKT Cell Development

Overview
Journal J Exp Med
Date 2005 Aug 10
PMID 16087715
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Upon reaching the mature heat stable antigen (HSA)low thymic developmental stage, CD1d-restricted Valpha14-Jalpha18 thymocytes undergo a well-characterized sequence of expansion and differentiation steps that lead to the peripheral interleukin-4/interferon-gamma-producing NKT phenotype. However, their more immature HSAhigh precursors have remained elusive, and it has been difficult to determine unambiguously whether NKT cells originate from a CD4+ CD8+ double-positive (DP) stage, and when the CD4+ and CD4- CD8- double-negative (DN) NKT subsets are formed. Here, we have used a CD1d tetramer-based enrichment strategy to physically identify HSAhigh precursors in thymuses of newborn mice, including an elusive DPlow stage and a CD4+ stage, which were present at a frequency of approximately 10(-6). These HSAhigh DP and CD4+ stages appeared to be nondividing, and already exhibited the same Vbeta8 bias that characterizes mature NKT cells. This implied that the massive expansion of NKT cells is separated temporally from positive selection, but faithfully amplifies the selected TCR repertoire. Furthermore, we found that, unlike the DN gammadelta T cells, the DN NKT cells did not originate from a pTalpha-independent pathway bypassing the DP stage, but instead were produced during a short window of time from the conversion of a fraction of HSAlow NK1.1neg CD4 cells. These findings identify the HSAhigh CD4+ stage as a potential branchpoint between NKT and conventional T lineages and between the CD4 and DN NKT sublineages.

Citing Articles

Eed-dependent histone modification orchestrates the iNKT cell developmental program alleviating liver injury.

Guo Y, Ohki S, Kawano Y, Kong W, Ohno Y, Honda H Front Immunol. 2024; 15:1467774.

PMID: 39372408 PMC: 11449725. DOI: 10.3389/fimmu.2024.1467774.


invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.

PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.


Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant natural killer T cell subset differentiation.

Amable L, Ferreira Martins L, Pierre R, Do Cruseiro M, Chabab G, Serge A Nat Commun. 2023; 14(1):7922.

PMID: 38040679 PMC: 10692182. DOI: 10.1038/s41467-023-43424-7.


TGF-β Promotes the Postselection Thymic Development and Peripheral Function of IFN-γ-Producing Invariant NKT cells.

Morgan R, Frank C, Greger M, Attaway M, Sigvardsson M, Bartom E J Immunol. 2023; 211(9):1376-1384.

PMID: 37702745 PMC: 10592054. DOI: 10.4049/jimmunol.2200809.


Impaired thymic iNKT cell differentiation at early precursor stage in murine haploidentical bone marrow transplantation with GvHD.

Zhao W, Wang Y, Zhang X, Hao J, Zhang K, Huang X Front Immunol. 2023; 14:1203614.

PMID: 37600815 PMC: 10438461. DOI: 10.3389/fimmu.2023.1203614.


References
1.
Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D . The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998; 395(6701):462-9. DOI: 10.1038/26683. View

2.
Borowski C, Bendelac A . Signaling for NKT cell development: the SAP-FynT connection. J Exp Med. 2005; 201(6):833-6. PMC: 2213098. DOI: 10.1084/jem.20050339. View

3.
Park S, Lemonnier F, Wang C, Bendelac A, Jabri B . Selection and expansion of CD8alpha/alpha(1) T cell receptor alpha/beta(1) intestinal intraepithelial lymphocytes in the absence of both classical major histocompatibility complex class I and nonclassical CD1 molecules. J Exp Med. 1999; 190(6):885-90. PMC: 2195634. DOI: 10.1084/jem.190.6.885. View

4.
Eberl G, MacDonald H . Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice. J Immunol. 1999; 163(8):4091-4. View

5.
Gadue P, Morton N, Stein P . The Src family tyrosine kinase Fyn regulates natural killer T cell development. J Exp Med. 1999; 190(8):1189-96. PMC: 2195667. DOI: 10.1084/jem.190.8.1189. View